Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632)

NCT03168464 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Non Small Cell Lung Cancer Metastatic

Interventions

DRUG: Ipilimumab
DRUG: Nivolumab
RADIATION: Radiation therapy

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]